Title: Unmasking the Hidden Epidemic: Primary Aldosteronism In the realm of hypertension, primary aldosteronism (PA) emerges as a critical but often overlooked player. Frequently misdiagnosed, PA presents unique challenges and opportunities in patient care. But why should we care about it, and how can we navigate its complexities? #PrimaryAldosteronism #Hypertension **Diagnosis and Screening** Diagnosing PA is paramount yet straightforward, involving a blood test measuring aldosterone and renin levels. Shockingly, less than 1% of hypertensive patients are screened for PA, despite its presence in up to 15% of cases. Screening is essential for anyone with hypertension, particularly those with type 2 diabetes, unexplained atrial fibrillation, or resistant hypertension. #ScreeningMatters #BloodPressure **Treatment Options** For unilateral PA, adrenalectomy offers a surgical cure, significantly enhancing blood pressure control and quality of life. However, it carries surgical risks and may lead to glucocorticoid insufficiency post-operation. For bilateral PA, lifelong medical therapy with mineralocorticoid receptor antagonists helps manage symptoms and reduce health risks. #Adrenalectomy #MedicalTherapy **The Impact** Primary aldosteronism is more than just high blood pressure. It heightens the risk of stroke and kidney disease by over double and places patients at thrice the risk for atrial fibrillation. By identifying and treating PA appropriately, we not only improve blood pressure management but also significantly reduce cardiovascular and renal complications. #HealthInnovation #Endocrinology In summary, screening for PA can significantly transform hypertension management, offering a pathway to targeted therapies. For those navigating hypertension’s complexities, considering primary aldosteronism might just be the game changer we need. Remember, effective diagnosis and tailored treatment hold the key to better health outcomes. Stay informed, stay healthy. #Cardiology #HealthcareR

Is low blood pressure hindering your heart failure treatment? How do you balance life-saving medications with hypotension? We explore the definitions, causes, and practical solutions to optimize patient care. Learn how to navigate ARNI, beta-blockers, SGLT2 inhibitors, and MRAs effectively.

In this episode of Cardio Buzz, we explore the intriguing concept of the 'legacy effect' of medications like those used in treating diabetes, hypertension, hypercholesterolemia, and chronic kidney disease. We'll delve into landmark studies like the UKPDS, Steno-2, and more, examining the lasting impacts of medications such as Repatha, Candesartan, and Empagliflozin. Learn how these drugs contribute to disease regression, modify genes, and prevent non-fatal events to grant long-term protective effects. 00:00 Introduction: The Challenge of Lifelong Medication 00:57 Exploring the Legacy Effect of Medications 01:33 Diabetes Medications: Long-Term Benefits 03:15 Hypertension Medications: Persistent Effects 03:58 Cholesterol Medications: Lasting Impact 04:49 Kidney Disease Medications: Prolonged Benefits 06:12 Understanding the Legacy Effect Mechanism 09:13 Implications and Final Thoughts

"This week, we delve into the complexities of Familial Hypercholesterolemia (FH) diagnosis and challenge the conventional Dutch Lipid Clinic Network Score. 🩺 Our analysis of a recent Austrian study reveals significant limitations in the score's practical application, including inconsistent scoring and poor record completion. 📝 Key findings: 📊 A single off-treatment LDL cholesterol level of 190 mg/dL demonstrates comparable, and potentially superior, performance to the complex Dutch Lipid Score in identifying individuals with genetically confirmed FH. ✅ This simplified approach offers enhanced index case identification and facilitates timely referrals for genetic testing. 💡 We explore how a simpler, LDL-focused strategy could change clinical practice. This episode is crucial for cardiologists and lipid specialists seeking to streamline FH screening and improve patient outcomes. 🎧 Tune in to learn more! We also discuss the need for further studies to validate this approach and assess its impact on diagnosis rates and cardiovascular outcomes. 🔬 Listen now to 'Ditching the Dutch: FH Diagnosis made easy' and join the conversation on the future of FH screening. #Cardiology #FH #Lipidology #MedicalResearch #ClinicalPractice #Diagnosis 🗣️"  

Join us in this episode of Cardio Buzz as we bring you the latest updates from the European Society of Cardiology conference held in London. Discover groundbreaking clinical trials and new guidelines that promise to reshape the practice of cardiology. We will break down the ten most impactful clinical trials and four new guidelines on hypertension, chronic coronary disease, atrial fibrillation, and peripheral/aortic diseases. Stay ahead in your field with our concise and insightful analysis. Subscribe, like, and hit the notification bell to stay informed on all cardiology advancements. 00:00 Introduction to the European Society of Cardiology Conference 00:59 Top 10 Late-Breaking Clinical Trials 04:41 New Guidelines Overview 05:38 Hypertension Guidelines 09:30 Chronic Coronary Artery Disease Guidelines 15:08 Peripheral Arterial and Aortic Disease Guidelines 20:33 Atrial Fibrillation Guidelines 23:58 Conclusion and Next Steps

In this episode of Cardio Buzz, the discussion focuses on the potential of stem cell therapy to transform cardiology. Host Dr. Hussain interviews Dr. Yahya Kiwan, an experienced cardiologist and stem cell research advocate. They explore the application of stem cells in treating advanced heart conditions, including post-myocardial infarction and chronic heart failure. The episode covers the sources of stem cells, their harvesting and injection techniques, clinical trial results, and success stories. Dr. Kiwan addresses the ethical considerations and the future of regenerative medicine, emphasizing the need for greater awareness and education in the field. The episode concludes with information on upcoming educational opportunities and fellowships in regenerative cardiology. 00:48 The Promise of Stem Cells in Cardiology 01:31 Interview with Dr. Yahya Kiwan 04:13 Sources and Types of Stem Cells 05:55 Stem Cell Therapy Techniques 10:45 Current Applications and Success Stories 17:18 Future Perspectives and Ethical Considerations 19:38 Learning More About Regenerative Medicine 21:20 Conclusion and Next Steps

In this episode of CardioBuzz, host Dr. Hussien discusses advanced CPR techniques and challenges from a cardiologist's perspective, featuring Dr. Naeem Toosy, a consultant in emergency medicine. The conversation delves into critical aspects like when to stop resuscitation, use of mechanical circulatory support devices, and the effectiveness of mechanical chest compression devices. Dr. Tusi outlines the significance of early recognition, the role of the public in initiating CPR, and the potential benefits of ECMO during CPR. He underscores the need for national-level education on CPR and the importance of the Good Samaritan law in encouraging public intervention during cardiac arrests. 00:00 Introduction to CardioBuzz 00:08 Overview of CPR Challenges 00:33 Introducing Dr. Naeem Toosy 01:36 Importance of Brain Resuscitation 03:11 When to Stop Resuscitation 06:20 Mechanical Chest Compression Devices 07:49 ECMO in CPR 13:04 National Strategies to Reduce Cardiovascular Mortality 18:04 Conclusion and Final Thoughts

In this episode of Cardio Buzz, host and guest Dr. Daniel Jones discuss contrast nephropathy, a kidney injury caused by contrast agents used in medical imaging, and a promising intervention to reduce its incidence. Dr. Jones explains that inorganic nitrates, which are naturally found in green leafy vegetables, have shown significant potential in preventing contrast-induced nephropathy and associated acute kidney injuries in a recent study. This study involved 640 high-risk patients and demonstrated that inorganic nitrates reduced kidney injuries by 60% and improved long-term cardiovascular outcomes. The episode concludes with a conversation about the practical implications and future research plans for this intervention.

Microplastics are small pieces of plastic less than five millimeters in size that result from the degradation of larger plastic items. Derived from synthetic materials such as polyethylene and polyvinyl chloride, plastics are known for their durability and low cost but pose significant environmental and health risks due to their inability to biodegrade. Microplastics, including even smaller nanoplastics, are found everywhere - in our food, water, air, and even within the human body, where they can be ingested, inhaled, or absorbed through the skin. Italian researchers published their work in March 2024, found microplastics in the atherosclerotic plaques of patients with carotid artery stenosis. This presence of micro and nanoplastics was associated with higher levels of inflammation and an increased risk of heart attacks and strokes. While this finding indicates a correlation rather than causation, it raises concerns about the potential health impacts of microplastics. We provide practical advice on minimizing exposure to microplastics, such as avoiding single-use plastics, choosing products with minimal or no plastic packaging, and opting for natural fibers over synthetic ones.   00:00 Introduction to Plastics: Types and Properties 00:26 The Environmental and Health Impact of Microplastics 01:39 Investigating Microplastics in Human Arteries: A Groundbreaking Study 02:25 Study Findings: Microplastics in Atherosclerotic Plaques 03:12 Implications of the Study: Association vs. Causation 03:44 Practical Steps to Minimize Microplastic Exposure 04:47 Conclusion: The Challenge of Avoiding Microplastics  

With #diabetes projected to affect 783 million patients globally, understanding its connection to #coronary disease, #heartfailure , and #kidneydisease is crucial. We explore the latest guidelines from the European Society of Cardiology and break down the essentials, from diabetes diagnosis to cardiovascular risk assessment, lifestyle modifications, glucose-lowering medications, and other topics.  #heart #healthcare #medicine #doctor #nurse #medical #coronavirus #covid19 #healthylifestyle #hospital #mentalhealth #dentistry #pharmacy #surgery #healthtips #weightloss #fitness #workout #diet #nutrition #exercise #wellness #selfcare #prevention #disease #treatment #research

لدينا جميعاً شعور أن حالات الموت المفاجئ ☠️ دون سابق إنذار قد زادت  بين أوساط الشباب والرياضيين 🏃‍♂️🏃‍♂️ وعندما اجتاحتنا الكورونا 😷😷😷 في سنة ألفين وعشرين وزادت معها معدل الوفيات طبعا وزاد معها شعورنا بكثرة حالات الموت المفاجئ ونسبها البعض الى الكورونا نفسها ونسبها البعض الآخر للتطعيمات أو اللقاحات واختلط في ذلك العلم.. بتأويلات مدّعي العلم وبنظريات المؤامرة فهل هناك علاقة بين الإصابة بالكورونا والموت المفاجئ   وماذا عن اللقاحات وأثرها؟💉💉 الإجابة المباشرة والقصيرة هي نعم  هناك ارتباط بين الإصابة بالكورونا وأمراض القلب والموت المفاجئ 💔💔❤️‍🩹 ونعم هناك ارتباط بين لقاحات الكورونا وبعض أمراض القلب 💔  ولكن دعونا نبدأ القصة من البداية 

في قديم الزمان ، كان البشر يعتقدون أن أقدارهم محددة في النجوم والأفلاك والكواكب ولايزال الكثير ممن أعرفهم يعتقدون أن أبراجهم الفلكية ترسم شخصياتهم وتحدد مصيرهم في الحياة  أما في الطب الحديث، وبدلاً من رسم خرائط الأبراج الفلكية ، يمكننا رسم خرائط للجينات.  وقد خريطة الجينات هذه على التنبؤ بمن سيمرض ومتى سيمرض وبأي مرض سيصاب.  ولكن أيهما أكثر تأثير على خطر الإصابة بأمراض القلب؟ جودة الجينات أم جودة العادات؟  هل يمكن إن وَرّثنا آباؤنا طفرات جينية واقية أن تحمينا من أثر العادات الصحية السيئة؟  وعلى العكس هل يمكن لنمط الحياة الصحي أن يحد من تأثير الطفرات الجينية المؤذية الموروثة؟

Welcome to ESC this year from Amsterdam, the city known of charming canals, cycling, and attractive architecture. There were 5 new guidelines, tens of session and 30 late-breaking clinical trials. In this episode, I've handpicked just seven trials. The choice was made based on the importance of the topics, the ability of the results to shake up the practice and challenge some cardiology dogmas. Some of the trials were positive, others were negative, but we learn in both cases. I'll be presenting the trials in ascending order of importance, saving the most impactful one for last. Here we go...

هل يجب أن نتناول الأسبرين بعد سن الأربعين لمنع النوبات القلبية والسكتات الدماغية أم لا؟ هل هو مفيد أم مضر؟

تستوستيرون هو هرمون الذكورة الذي يمنح الرجال القوة والدافع والعزيمة لتحقيق الأهداف. انخفاض مستويات التستوستيرون يؤدي الى فتور الرغبة الجنسية وضعف الانتصاب والإرهاق وضعف العضلات والاكتئاب والدوار وانخفاض كثافة العظام.  هل يؤثر ذلك على صحة القلب؟ ماذا يحدث إذا قمنا بتصحيح نقص التستوستيرون باستخدام التستوستيرون الخارجي؟ هل سيؤذي القلب أم يشفيه؟ ماذا تخبرنا أحدث الأبحاث عن تعويض التستوستيرون وتأثيره على القلب؟

A shot to treat Blood Pressure for 6 months

Testosterone is the primal essence of manhood. Testosterone is the gift that gives men the strength, the drive, and the resolve to achieve goals. It's part of what makes man a man.   But what happens when testosterone levels drop? Does that affect the heart's health? What happens if we correct testosterone deficiency with exogenous testosterone? Will it damage the heart or heal it?  What does the latest research on testosterone replacement tell us? 

What is the difference between cholesterol and LDL cholesterol?  What evidence do we have that link cholesterol and heart disease? How convincing is that evidence? Is it a myth created by the drug industry or is it a fact backed by science? Let's answer all of these questions in this episode